This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Differences in trajectory of disease activity according to biologic and targeted synthetic disease-modifying anti-rheumatic drug treatment in patients with rheumatoid arthritis
Arthritis Research & Therapy Open Access 14 October 2022
-
Treatment Patterns Among Patients with Rheumatoid Arthritis in Puerto Rico
Rheumatology and Therapy Open Access 24 January 2022
-
Therapeutic effect of various ginsenosides on rheumatoid arthritis
BMC Complementary Medicine and Therapies Open Access 25 May 2021
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Rent or buy this article
Get just this article for as long as you need it
$39.95
Prices may be subject to local taxes which are calculated during checkout

Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Related links
FURTHER INFORMATION
PowerPoint slides
Rights and permissions
About this article
Cite this article
Chaudhari, K., Rizvi, S. & Syed, B. Rheumatoid arthritis: current and future trends. Nat Rev Drug Discov 15, 305–306 (2016). https://doi.org/10.1038/nrd.2016.21
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd.2016.21
This article is cited by
-
Differences in trajectory of disease activity according to biologic and targeted synthetic disease-modifying anti-rheumatic drug treatment in patients with rheumatoid arthritis
Arthritis Research & Therapy (2022)
-
Treatment Patterns Among Patients with Rheumatoid Arthritis in Puerto Rico
Rheumatology and Therapy (2022)
-
Therapeutic effect of various ginsenosides on rheumatoid arthritis
BMC Complementary Medicine and Therapies (2021)
-
The Evaluation of 68Ga-Citrate PET/CT Imaging for Dihydroartemisinin in the Treatment of Rheumatoid Arthritis
Molecular Imaging and Biology (2021)
-
Identification and preclinical development of an anti-proteolytic uPA antibody for rheumatoid arthritis
Journal of Molecular Medicine (2020)